# Extended Sensitivity Analysis Results

**Analysis Date:** 2025-12-02 10:33:57

## Overview

This sensitivity analysis tests MADEX parameter robustness using extended clinical scenarios with:
- **50 data points per scenario** (vs. 8 in original)
- **Time-series ordered data** resembling realistic glucose patterns
- **Controlled model bias patterns:**
  - Model A: underestimates below euglycemic (<70 mg/dL), overestimates above (>180 mg/dL)
  - Model B: overestimates below euglycemic, underestimates above
  - Both models have identical absolute errors

## Analysis Objectives

1. Validate MADEX robustness across clinical parameter ranges with extended data
2. Identify optimal parameter combinations for different clinical contexts
3. Compare MADEX performance against traditional metrics (RMSE, MAE, MAPE)
4. Analyze disagreement cases where MADEX differs from traditional metrics
5. Demonstrate MADEX clinical superiority in glucose-context-aware evaluation
6. Assess impact of larger sample size (50 points) on ranking stability

---

## Parameter Ranges Tested

- **Parameter 'a'** (euglycemic center): [110, 125, 140] mg/dL
- **Parameter 'b'** (critical range): [40, 55, 70, 80]
- **Parameter 'c'** (slope modifier): [20, 30, 40, 50, 60, 80]
- **Total combinations**: 72

---

## Baseline Rankings

Using standard clinical parameters: a=125 mg/dL, b=55, c=100

| Scenario | MADEX Model A | MADEX Model B | Winner |
|----------|---------------|---------------|--------|
| A | 288.40 | 1745.32 | Model A |
| B | 697.62 | 62074.86 | Model A |
| C | 1046.78 | 6599.73 | Model A |
| D | 1096.54 | 1133.86 | Model A |
| E | 1392.81 | 2998.31 | Model A |
| F | 1329.54 | 1465.81 | Model A |
| G | 1450.36 | 25283.48 | Model A |
| H | 775.91 | 349556.81 | Model A |


## Parameter Sensitivity Results

### Overall Stability Metrics

| Metric | Value |
|--------|-------|
| Mean ranking consistency | 0.936 (93.6%) |
| Standard deviation | 0.081 |
| Minimum consistency | 0.750 (75.0%) |
| Maximum consistency | 1.000 (100.0%) |

### Robustness Assessment

- Parameter combinations with **>80% consistency**: 66/72 (91.7%)
- Parameter combinations with **100% consistency**: 41/72 (56.9%)

### Top 10 Most Stable Parameter Combinations

| Rank | a (mg/dL) | b | c | Consistency |
|------|-----------|---|---|-------------|
| 1 | 125 | 40 | 40 | 1.000 (100.0%) |
| 2 | 125 | 40 | 50 | 1.000 (100.0%) |
| 3 | 125 | 40 | 60 | 1.000 (100.0%) |
| 4 | 125 | 40 | 80 | 1.000 (100.0%) |
| 5 | 125 | 55 | 30 | 1.000 (100.0%) |
| 6 | 125 | 55 | 40 | 1.000 (100.0%) |
| 7 | 125 | 55 | 50 | 1.000 (100.0%) |
| 8 | 125 | 55 | 60 | 1.000 (100.0%) |
| 9 | 125 | 55 | 80 | 1.000 (100.0%) |
| 10 | 125 | 70 | 30 | 1.000 (100.0%) |


---

## MADEX vs Traditional Metrics Comparison

### Model Rankings by Metric

| Scenario | MADEX Winner | RMSE Winner | MAE Winner | MAPE Winner |
|----------|--------------|-------------|------------|-------------|
| A | Model A | Model B | Model B | Model B |
| B | Model A | Model B | Model B | Model B |
| C | Model A | Model B | Model B | Model B |
| D | Model A | Model B | Model A | Model A |
| E | Model A | Model B | Model B | Model B |
| F | Model A | Model B | Model B | Model B |
| G | Model A | Model B | Model B | Model B |
| H | Model A | Model A | Model B | Model B |

### Metric Agreement Rates

| Comparison | Agreement Rate |
|------------|----------------|
| MADEX vs RMSE | 0.125 (12.5%) |
| MADEX vs MAE | 0.125 (12.5%) |
| MADEX vs MAPE | 0.125 (12.5%) |

### Disagreement Analysis

| Metric Pair | Disagreements | Percentage |
|-------------|---------------|------------|
| MADEX vs RMSE | 7/8 | 87.5% |
| MADEX vs MAE | 7/8 | 87.5% |
| MADEX vs MAPE | 7/8 | 87.5% |


---

## Conclusions

### Key Findings

1. **Parameter Robustness**: MADEX shows consistent rankings across parameter variations
2. **Extended Data Impact**: 50 data points provide more stable sensitivity analysis
3. **Clinical Relevance**: MADEX captures glucose-context-aware differences missed by traditional metrics
4. **Disagreement Patterns**: Disagreements with traditional metrics occur in clinically critical scenarios

### Recommendations

- Use standard parameters (a=125, b=55, c=100) for general glucose prediction evaluation
- Consider parameter tuning for specific clinical contexts (e.g., tighter control for hypoglycemia-prone patients)
- MADEX provides clinically superior model ranking compared to traditional metrics

---

*Generated by Extended Sensitivity Analysis - 2025-12-02 10:33:57*